| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/03/2001 | CN1278809A Substituted benzodihydropyran derivatives |
| 01/03/2001 | CN1278806A Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
| 01/03/2001 | CN1278802A Benzoxazine and Benzothiazine derivatives and their use in pharmaceuticals |
| 01/03/2001 | CN1278795A Process for making diaryl pyridines useful as cox-2 inhibitors |
| 01/03/2001 | CN1278794A Substituted di-hydroxyl-indol derivatives as protein tyrosine kinase and as protein serine/threenine kinase inhibitors |
| 01/03/2001 | CN1278790A Chemical compound |
| 01/03/2001 | CN1278789A 9,10-Dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 01/03/2001 | CN1278736A Hmanized antibodies to human gp39, compositions containing and therapeutic use thereof |
| 01/03/2001 | CN1278734A Methods and compositions for treating rheumatoid arthritis |
| 01/03/2001 | CN1278530A Novel peptide derivative |
| 01/03/2001 | CN1278446A Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease |
| 01/03/2001 | CN1278434A Tumor pain relieving ointment and its preparation |
| 01/03/2001 | CN1278430A Composite Triamcinolone Acetonide medicine for treating germ-free inflammation |
| 01/03/2001 | CN1060171C Substituted biphenyl isoxazole sulfonamides |
| 01/03/2001 | CN1060163C Acylated aminoalknimidazoles and aminoalkyl triazoles |
| 01/03/2001 | CN1060072C Wind-expelling medicinal liquor |
| 01/03/2001 | CN1060068C Ointment of drawing ot pus for curing bone inflammation and preparation technology thereof |
| 01/03/2001 | CN1060064C Non-toxic sedative anticancer Chinese medicine capsule |
| 01/03/2001 | CN1060057C Liniment for treating pain resulted from rheumatism |
| 01/02/2001 | US6169092 3-Ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes |
| 01/02/2001 | US6169090 Heterocyclic compounds and their therapeutic use |
| 01/02/2001 | US6169068 Treating lung disease or disorder by inhalating a protein |
| 01/02/2001 | US6168920 Extracellular adhesive proteins |
| 01/02/2001 | US6168784 Block the inflammatory effects of rantes, and are useful for the treatment of asthma, allergic rhinitis, atopic dermatitis, atheroma/atherosclerosis, rheumatoid arthritis and hiv infections |
| 01/02/2001 | CA2025070C Recombinant aprotinin variants genetically engineered process for the microbial preparation of homgeneously processed aprotinin variants and the therapeutic use thereof |
| 01/02/2001 | CA2009604C Diaryl-substituted heterocyclic compounds, their preparation and drugs and cosmetics obtained therefrom |
| 01/01/2001 | WO2001003645A2 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 12/30/2000 | CA2312633A1 Combination therapy for the treatment of migraine |
| 12/30/2000 | CA2312631A1 5ht1 receptor agonists, caffeine and either a cox-2 inhibitor or nsaid for the treatment of migraine |
| 12/28/2000 | WO2000078980A1 Method for producing plants with increased flavonoid and phenolic compound content |
| 12/28/2000 | WO2000078954A2 Human transcriptional regulator proteins |
| 12/28/2000 | WO2000078953A2 Human transport proteins |
| 12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
| 12/28/2000 | WO2000078941A2 Methods and products for manipulating uncoupling protein expression |
| 12/28/2000 | WO2000078815A1 ANTI-αvβ3? RECOMBINANT HUMAN ANTIBODIES, NUCLEIC ACIDS ENCODING SAME AND METHODS OF USE |
| 12/28/2000 | WO2000078812A1 Method and compounds for inhibiting activity of serine elastases |
| 12/28/2000 | WO2000078804A1 Immune response regulatory proteins |
| 12/28/2000 | WO2000078794A1 Cysteinyl protease inhibitors |
| 12/28/2000 | WO2000078779A2 N-pyrazole a2a receptor agonists |
| 12/28/2000 | WO2000078777A1 Propargyl phenyl ether a2a receptor agonists |
| 12/28/2000 | WO2000078776A2 Thiophene a2a receptor agonists |
| 12/28/2000 | WO2000078757A1 Inhibitors of il-12 production |
| 12/28/2000 | WO2000078750A1 New pharmaceutically active compounds |
| 12/28/2000 | WO2000078746A1 Antiviral agents |
| 12/28/2000 | WO2000078731A1 5-cyano-2-aminopyrimidine derivatives |
| 12/28/2000 | WO2000078720A1 Novel dihydropyridine derivative |
| 12/28/2000 | WO2000078719A1 Dihydropyridine derivative |
| 12/28/2000 | WO2000078697A2 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
| 12/28/2000 | WO2000078360A1 Compositions and methods for the treatment or prevention of autoimmune disorders |
| 12/28/2000 | WO2000078341A1 A method for the prophylaxis and/or treatment of medical disorders |
| 12/28/2000 | WO2000078337A1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies |
| 12/28/2000 | WO2000078332A2 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 12/28/2000 | WO2000078324A1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof |
| 12/28/2000 | WO2000078322A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 12/28/2000 | WO2000078319A1 Dihydropyrazine derivatives as npy antagonists |
| 12/28/2000 | WO2000078317A1 Integrin receptor antagonists |
| 12/28/2000 | WO2000078299A2 Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy |
| 12/28/2000 | WO2000078294A2 Oral administration form for administering a fixed tramadol and diclofenac combination |
| 12/28/2000 | WO2000078266A2 Interferon tau mutants and methods for making them |
| 12/28/2000 | WO2000061551A3 Pyrimidine-2-one derivatives as integrin receptor ligands |
| 12/28/2000 | WO2000056353A3 A uro-genital condition treatment system |
| 12/28/2000 | WO2000054780A3 Corticosteroid formulation |
| 12/28/2000 | WO2000043495A3 33 human secreted proteins |
| 12/28/2000 | WO2000043373A3 Kinase inhibitors |
| 12/28/2000 | WO2000034474A3 Growth factor homolog zvegf3 |
| 12/28/2000 | WO2000032776A3 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| 12/28/2000 | WO2000031093A3 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation |
| 12/28/2000 | WO1999052493A3 Compounds that inhibit the binding of integrins to their receptors |
| 12/28/2000 | DE19929410A1 New octapepide compounds as alpha v beta 6 integrin inhibitors useful for treating and diagnosing heart disease, tumors, osteoporosis, fibrosis, inflammation, infection and psoriasis |
| 12/28/2000 | CA2382425A1 Interferon tau mutants and methods for making them |
| 12/28/2000 | CA2377698A1 Dihydropyrazine derivatives as npy antagonists |
| 12/28/2000 | CA2377530A1 Compositions and methods for the treatment or prevention of autoimmune disorders |
| 12/28/2000 | CA2377357A1 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 12/28/2000 | CA2376284A1 A method for the prophylaxis and/or treatment of medical disorders |
| 12/28/2000 | CA2376081A1 Cysteinyl protease inhibitors |
| 12/28/2000 | CA2376077A1 Integrin receptor antagonists |
| 12/28/2000 | CA2375508A1 Methods and products for manipulating uncoupling protein expression |
| 12/28/2000 | CA2375493A1 Human transport proteins |
| 12/28/2000 | CA2375414A1 Human transcriptional regulator proteins |
| 12/28/2000 | CA2375407A1 Rna metabolism proteins |
| 12/28/2000 | CA2375396A1 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
| 12/28/2000 | CA2375236A1 Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of use |
| 12/28/2000 | CA2375229A1 Method and compounds for inhibiting activity of serine elastases |
| 12/28/2000 | CA2375211A1 Antiviral agents |
| 12/28/2000 | CA2375182A1 5-cyano-2-aminopyrimidine derivatives |
| 12/28/2000 | CA2373375A1 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 12/28/2000 | CA2340319A1 Method for producing plants with increased flavonoid and phenolic compound content |
| 12/27/2000 | EP1063228A1 Cycloalkene derivatives, process for producing the same, and use |
| 12/27/2000 | EP1062336A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins |
| 12/27/2000 | EP1062326A1 Glycosyl sulfotransferase-3 |
| 12/27/2000 | EP1062236A1 31 human secreted proteins |
| 12/27/2000 | EP1062229A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 12/27/2000 | EP1062222A1 Serine peptidase modulators |
| 12/27/2000 | EP1062216A1 Inhibitors of phospholipase a2 |
| 12/27/2000 | EP1062214A1 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnfa levels |
| 12/27/2000 | EP1062210A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 12/27/2000 | EP1062209A1 Metabolically inert anti-inflammatory and anti-tumor antifolates |
| 12/27/2000 | EP1062205A2 Inhibitors of phospholipase enzymes |
| 12/27/2000 | EP1061926A2 Heterocyclic compounds, their production and use as tachykinin receptor antagonists |
| 12/27/2000 | EP1061916A2 Use os nitrone compounds for the inhibition of angiogenesis |